ArrowMark Colorado Holdings’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

ArrowMark Colorado Holdings’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,074,964	Closed	-$3.91M	–	330
2019 Q4	$3.91M	Sell	1,074,964 -3,571,279	-77%	-$28.9M	0.03%	216
2019 Q3	$38.5M	Buy	4,646,243 +857,480	+23%	+$6.94M	0.38%	72
2019 Q2	$32.6M	Buy	3,788,763 +256,972	+7%	+$2.3M	0.31%	88
2019 Q1	$37.8M	Buy	3,531,791 +551,105	+18%	+$5.9M	0.36%	82
2018 Q4	$26.1M	Buy	2,980,686 +596,959	+25%	+$7.6M	0.27%	101
2018 Q3	$40M	Buy	2,383,727 +2,333,403	+4,637%	+$50.5M	0.34%	92
2018 Q2	$1.05M	Buy	+50,324	New	+$932K	0.01%	293

Other funds holding SPPI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

ArrowMark Colorado Holdings's SPPI Position: Q1 2020 in Review

ArrowMark Colorado Holdings sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q1 2020, closing a stake of 1,074,964 shares — an estimated $3.91M sold.

ArrowMark Colorado Holdings first reported a position in SPPI in Q2 2018 and held it in 7 quarters. The position peaked at $40M in Q3 2018. 156 funds tracked by Wall St. Rank hold SPPI as of Q1 2020.

ArrowMark Colorado Holdings reported no remaining Spectrum Pharmaceuticals Inc position as of Q1 2020 after selling out during the quarter.
ArrowMark Colorado Holdings sold 1,074,964 Spectrum Pharmaceuticals Inc shares in Q1 2020, an estimated $3.91M.
ArrowMark Colorado Holdings first reported a position in Spectrum Pharmaceuticals Inc in Q2 2018 and held it in 7 quarters.
ArrowMark Colorado Holdings's Spectrum Pharmaceuticals Inc position peaked at $40M in Q3 2018.
156 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q1 2020.

Based on ArrowMark Colorado Holdings's 13F filing for Q1 2020, filed 15 May 2020.